Across TCGA pan-cancer cohorts, SLC29A4P2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SLC29A4P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SLC29A4P2 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC29A4P2 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

BRCA, HNSC, and KIRC are the cancer types where SLC29A4P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC29A4P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	−0.007	.003	6	view →
HNSC	All	II,III,IV	+0.008	.011	4	view →
KIRC	All	All	+0.008	.013	3	view →
PRAD	All	All	+0.012	.047	2	view →
THCA	All	All	−0.006	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: SLC29A4P2 RNA expression & survival · all SLC29A4P2 data types